CLINICAL TRIAL HIGHLIGHTS: O.3a 2.5-years of vamorolone treatment in Duchenne muscular dystrophy: Results of an open label long-term extension

Saved in:
Bibliographic Details
Published inNeuromuscular disorders : NMD Vol. 31; p. S48
Main Authors Hoffman, E., Dang, U., Clemens, P., Gordish-Dressman, H., Schwartz, B., Mengle-Gaw, L., Leinonen, M., Smith, E., Castro, D., Kuntz, N., Finkel, R., Tulinius, M., Nevo, Y., Ryan, M., Webster, R., van den Anker, J., Ward, L., Damsker, J., McDonald, C., Guglieri, M., Mah, J.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.10.2021
Online AccessGet full text

Cover

More Information
ISSN:0960-8966
1873-2364
DOI:10.1016/j.nmd.2021.07.020